| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_143bc38b69048a023ae2b9ff9ae392e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2b97cadfe3493436619037687ef7fcb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2007-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adc2f0b5dad7525754738aeb0123f2f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ac067fa40a99e105693f7da7621b074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e8670612ff936f20a7c5091af7d47c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c64833ae9d87c3110023d6b73f2ce42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2dedc45063b6deb75992776d2f7b85a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d750a959b3b9548923096ad6e429f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45fb4db792a66944f481dbf04f4faf36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1954ff6141527bbf0af218815b3a89b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a99d0eac0f95eb6ebeab3fe7c5110bdc |
| publicationDate |
2016-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2662626-C |
| titleOfInvention |
Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| abstract |
The present invention relates to compounds of the general formula (I) which are inhibitors of 5'-methylthioadenosine phosphorylase or 5'-methylthioadenosine nucleosidase. The invention also relates to the use of these compounds in the treatment of diseases or conditions in which it is desirable to inhibit 5'-methylthioadenosine phosphorylase or 5'-methylthioadenosine nucleosidase including cancer, and to pharmaceutical compositions containing the compounds. (see formula I) |
| priorityDate |
2006-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |